Formations of, Acquisitions by, and Mergers of Bank Holding Companies, 6148 [2019-03297]
Download as PDF
<![CDATA[
6148
Federal Register / Vol. 84, No. 38 / Tuesday, February 26, 2019 / Notices
308, 309(j), 310 and 610 of the
Communications Act of 1934, as
amended.
Total Annual Burden: 13,049 hours.
Total Annual Cost: No cost.
Privacy Impact Assessment: No
impact.
Nature and Extent of Confidentiality:
Information requested in the reports
may include confidential information.
However, covered entities can request
that such materials submitted to the
Commission be withheld from public
inspection.
Needs and Uses: After the 60-day
comment period expires, the
Commission will submit the revised
information collection to the Office of
Management and Budget (OMB) to
obtain a full three-year clearance. The
changes being made to the information
collect concern the Commission’s
wireless hearing aid combability rules
as they relate to the obligations of
wireless service providers to post
certain information on their websites,
retain information and to file annual
compliance certifications. No changes
are being made to the website posting
and reporting burdens of wireless
handset manufacturers. Further, no
changes are being made to the
information collection as related to
standards development, labeling and
disclosure requirements, and the
approved number of estimated
respondents/responses.
The revisions to the information
collection are necessitated by a Report
and Order in WT Docket No. 17–228,
FCC 18–167, adopted on November 15,
2018. In this Report and Order, the
Commission revised its rules requiring
service providers to post on their
publicly accessible websites information
regarding the hearing aid compatibility
of their offered handsets and required
them to retain certain information
regarding the hearing aid compatibility
of handsets they previously offered.
Through this information, consumers
will have access to the most recent data
about hearing aid-compatible handsets
and the Commission will be able to
ensure compliance with the hearing aid
compatibility rules and requirements. In
addition, the Commission determined
that service providers are no longer
required to file FCC Form 655 on an
annual basis. Instead, providers must
file an annual certification indicating
whether they are compliant with the
hearing aid compatibility rules.
As part of these revisions to the
wireless hearing aid compatibility
information collection, the Commission
is requesting approval of certain
changes to the form and the related
instructions. These changes to the form
VerDate Sep<11>2014
16:24 Feb 25, 2019
Jkt 247001
and its instructions implement the new
certification compliance requirement for
service providers and maintain the
existing compliance requirements for
device manufacturers. These changes to
the form reduce service providers’
regulatory burden while continuing to
allow the Commission to monitor
compliance with the hearing aid
compatibility rules.
Federal Communications Commission.
Marlene Dortch,
Secretary, Office of the Secretary.
[FR Doc. 2019–03234 Filed 2–25–19; 8:45 am]
BILLING CODE 6712–01–P
FEDERAL RESERVE SYSTEM
Formations of, Acquisitions by, and
Mergers of Bank Holding Companies
The companies listed in this notice
have applied to the Board for approval,
pursuant to the Bank Holding Company
Act of 1956 (12 U.S.C. 1841 et seq.)
(BHC Act), Regulation Y (12 CFR part
225), and all other applicable statutes
and regulations to become a bank
holding company and/or to acquire the
assets or the ownership of, control of, or
the power to vote shares of a bank or
bank holding company and all of the
banks and nonbanking companies
owned by the bank holding company,
including the companies listed below.
The applications listed below, as well
as other related filings required by the
Board, are available for immediate
inspection at the Federal Reserve Bank
indicated. The applications will also be
available for inspection at the offices of
the Board of Governors. Interested
persons may express their views in
writing on the standards enumerated in
the BHC Act (12 U.S.C. 1842(c)). If the
proposal also involves the acquisition of
a nonbanking company, the review also
includes whether the acquisition of the
nonbanking company complies with the
standards in section 4 of the BHC Act
(12 U.S.C. 1843). Unless otherwise
noted, nonbanking activities will be
conducted throughout the United States.
Unless otherwise noted, comments
regarding each of these applications
must be received at the Reserve Bank
indicated or the offices of the Board of
Governors not later than March 25,
2019.
A. Federal Reserve Bank of
Philadelphia (William Spaniel, Senior
Vice President) 100 North 6th Street,
Philadelphia, Pennsylvania 19105–
1521. Comments can also be sent
electronically to
Comments.applications@phil.frb.org:
1. Orrstown Financial Services,
Shippensburg, Pennsylvania; to merge
PO 00000
Frm 00022
Fmt 4703
Sfmt 4703
with Hamilton Bancorp, Townson, MD,
and thereby indirectly acquire Hamilton
Bank, Townson, Maryland.
B. Federal Reserve Bank of Atlanta
(Kathryn Haney, Assistant Vice
President) 1000 Peachtree Street NE,
Atlanta, Georgia 30309. Comments can
also be sent electronically to
Applications.Comments@atl.frb.org:
1. LexPark Holdings—STC, LLC,
SouthernTrust Group, LP &
SouthernTrust Holdings, Inc., Orlando,
Florida; to become a bank holding
company by acquiring voting shares of
First City Bank of Florida, Fort Walton
Beach, Florida.
Board of Governors of the Federal Reserve
System, February 21, 2019.
Yao-Chin Chao,
Assistant Secretary of the Board.
[FR Doc. 2019–03297 Filed 2–25–19; 8:45 am]
BILLING CODE P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2018–D–4367]
Bioavailability Studies Submitted in
New Drug Applications or
Investigational New Drug
Applications—General Considerations;
Draft Guidance for Industry;
Availability
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice of availability.
The Food and Drug
Administration (FDA or Agency) is
announcing the availability of a draft
guidance for industry entitled
‘‘Bioavailability Studies Submitted in
NDAs or INDs—General
Considerations.’’ This draft guidance
provides recommendations to sponsors
planning to include bioavailability (BA)
information for drug products in
investigational new drug applications
(INDs), new drug applications (NDAs),
and NDA supplements. This draft
guidance revises and replaces FDA’s
March 2014 draft guidance for industry
entitled ‘‘Bioavailability and
Bioequivalence Studies Submitted in
NDAs or INDs—General
Considerations,’’ which addresses BA or
bioequivalence (BE) studies for INDs,
NDAs, and NDA supplements.
DATES: Submit either electronic or
written comments on the draft guidance
by May 28, 2019 to ensure that the
Agency considers your comment on this
draft guidance before it begins work on
the final version of the guidance.
SUMMARY:
E:\FR\FM\26FEN1.SGM
26FEN1
]]>Agencies
[Federal Register Volume 84, Number 38 (Tuesday, February 26, 2019)]
[Notices]
[Page 6148]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-03297]
=======================================================================
-----------------------------------------------------------------------
FEDERAL RESERVE SYSTEM
Formations of, Acquisitions by, and Mergers of Bank Holding
Companies
The companies listed in this notice have applied to the Board for
approval, pursuant to the Bank Holding Company Act of 1956 (12 U.S.C.
1841 et seq.) (BHC Act), Regulation Y (12 CFR part 225), and all other
applicable statutes and regulations to become a bank holding company
and/or to acquire the assets or the ownership of, control of, or the
power to vote shares of a bank or bank holding company and all of the
banks and nonbanking companies owned by the bank holding company,
including the companies listed below.
The applications listed below, as well as other related filings
required by the Board, are available for immediate inspection at the
Federal Reserve Bank indicated. The applications will also be available
for inspection at the offices of the Board of Governors. Interested
persons may express their views in writing on the standards enumerated
in the BHC Act (12 U.S.C. 1842(c)). If the proposal also involves the
acquisition of a nonbanking company, the review also includes whether
the acquisition of the nonbanking company complies with the standards
in section 4 of the BHC Act (12 U.S.C. 1843). Unless otherwise noted,
nonbanking activities will be conducted throughout the United States.
Unless otherwise noted, comments regarding each of these
applications must be received at the Reserve Bank indicated or the
offices of the Board of Governors not later than March 25, 2019.
A. Federal Reserve Bank of Philadelphia (William Spaniel, Senior
Vice President) 100 North 6th Street, Philadelphia, Pennsylvania 19105-
1521. Comments can also be sent electronically to
Comments.applications@phil.frb.org:
1. Orrstown Financial Services, Shippensburg, Pennsylvania; to
merge with Hamilton Bancorp, Townson, MD, and thereby indirectly
acquire Hamilton Bank, Townson, Maryland.
B. Federal Reserve Bank of Atlanta (Kathryn Haney, Assistant Vice
President) 1000 Peachtree Street NE, Atlanta, Georgia 30309. Comments
can also be sent electronically to Applications.Comments@atl.frb.org:
1. LexPark Holdings--STC, LLC, SouthernTrust Group, LP &
SouthernTrust Holdings, Inc., Orlando, Florida; to become a bank
holding company by acquiring voting shares of First City Bank of
Florida, Fort Walton Beach, Florida.
Board of Governors of the Federal Reserve System, February 21,
2019.
Yao-Chin Chao,
Assistant Secretary of the Board.
[FR Doc. 2019-03297 Filed 2-25-19; 8:45 am]
BILLING CODE P
